10026998: HALOPERIDOL INJECTION.
The HALOPERIDOL INJECTION is a the manufacturer industrial component. Key specifications include administration: INTRAMUSCULAR, primary_container_type: VIAL, total_primary_container_quantity: 25, primary_container_content_quantity: 1.0 MILLILITERS, part_name_assigned_by_controlling_agency: HALOPERIDOL INJ 5MG 1ML VIAL PACKAGE 25EA. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-694-5455, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAMUSCULAR |
| special_features | HALOPERIDOL 5 MG/ML INJECTION SOLUTION SUPPLIED AS 5MG PER ML, 1ML FILL IN A 2ML VIAL. STORE AT 20 TO 25C (68 TO 77F) USP CONTROLLED ROOM TEMPERATURE. DO NOT FREEZE. PROTECT FROM LIGHT. |
| primary_container_type | VIAL |
| total_primary_container_quantity | 25 |
| primary_container_content_quantity | 1.0 MILLILITERS |
| part_name_assigned_by_controlling_agency | HALOPERIDOL INJ 5MG 1ML VIAL PACKAGE 25EA |
| NSN | 6505-01-694-5455 |
| ADMINISTRATION | INTRAMUSCULAR |
| PRIMARY CONTAINER CONTENT QUANTITY | 1.0 MILLILITERS |
| PRIMARY CONTAINER TYPE | VIAL |
| SPECIAL FEATURES | HALOPERIDOL 5 MG/ML INJECTION SOLUTION SUPPLIED AS 5MG PER ML, 1ML FILL IN A 2ML VIAL. STORE AT 20 TO 25C (68 TO 77F) USP CONTROLLED ROOM TEMPERATURE. DO NOT FREEZE. PROTECT FROM LIGHT. |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | HALOPERIDOL INJ 5MG 1ML VIAL PACKAGE 25EA |
| TOTAL PRIMARY CONTAINER QUANTITY | 25 |